期刊
THERAPEUTIC DELIVERY
卷 8, 期 5, 页码 343-355出版社
FUTURE SCI LTD
DOI: 10.4155/tde-2017-0011
关键词
nonviral delivery vectors; RNAi; TNF-alpha siRNA
Immune-mediated diseases are emerging as a major healthcare concern in the present era. TNF-alpha, a proinflammatory cytokine, plays a major role in the manifestation of these diseases by mediating different pathways and inducing the expression of other cytokines. In last decades, monoclonal antibodies and extracellular portion of human TNF-alpha receptors are explored in this area; however, the risk of immunological response and undesired effects urge a need to develop more effective therapies to control TNF-alpha levels. siRNA therapeutic strategies are emerging for the treatment of myriad of diseases, but the delivery challenges associated with siRNA require the development of suitable delivery vectors. For delivery of TNF-alpha siRNA, both viral and nonviral vectors are explored. This review attempts to describe different delivery approaches for TNF-alpha siRNA with special focus on nonviral delivery vectors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据